• HOME
  •  > 
  • 看護学
  •  > 
  • 雑誌
  •  >  with NEO(ウィズネオ) 2022年秋季増刊号 新生児の生理・徴候と代表的疾患まるごとガイド

with NEO(ウィズネオ) 2022年秋季増刊号 新生児の生理・徴候と代表的疾患まるごとガイド

出版社: メディカ出版
発行日: 2022-09-10
分野: 看護学  >  雑誌
ISBN: 9784840476348
ISSN: 24344540
雑誌名:
特集: 新生児の生理・徴候と代表的疾患まるごとガイド
電子書籍版: 2022-09-10 (電子書籍版)
書籍・雑誌
≪全国送料無料でお届け≫
取寄せ目安:約3営業日

5,500 円(税込)

電子書籍
章別単位での購入はできません
ブラウザ、アプリ閲覧

5,500 円(税込)

目次

  • 特集 ケアの介入・搬送・報告のタイミングが変わる!
       新生児の生理・徴候と代表的疾患まるごとガイド

    【第1章 胎児・新生児の基礎知識】
    01 胎児肺の成長・発達と出生後の呼吸の適応生理
    02 胎生期の循環器系の形態形成と出生後の循環の適応生理
    03 出生後の体温調節の特徴
    04 早産児の神経発達
    05 胎児・新生児の消化管の発達
    06 新生児のビリルビンの産生と代謝・排泄

    【第2章 新生児の主な徴候】
    01 呼吸障害
    02 チアノーゼ
    03 体温の異常
    04 新生児発作
    05 嘔吐・血便
    06 黄疸
    07 not doing well

    【第3章 新生児の代表的疾患】
    ■1 呼吸器系の疾患
    01 無呼吸発作
    02 呼吸窮迫症候群(RDS)
    03 新生児一過性多呼吸(TTN)
    04 胎便吸引症候群(MAS)
    05 慢性肺疾患(CLD/BPD)
    ■2 循環器系の疾患
    01 未熟児動脈管開存症(PDA)
    02 晩期循環不全(LCC)
    03 新生児遷延性肺高血圧症(PPHN)
    04 出生後早期に問題となる先天性心疾患
    ■3 中枢神経系の疾患
    01 脳室内出血(IVH)
    02 脳室周囲白質軟化症(PVL)
    03 新生児低酸素性虚血性脳症(HIE)
    ■4 消化器系の疾患
    01 壊死性腸炎(NEC)・限局性腸穿孔(FIP)
    02 胎便関連性腸閉塞(MRI)
    03 先天性食道閉鎖症
    04 直腸肛門形成異常
    05 腸回転異常症
    06 腹壁破裂・臍帯ヘルニア
    ■5 栄養・代謝および免疫系の疾患
    01 新生児低血糖
    02 新生児病的黄疸
    03 早産児骨減少症
    04 新生児・乳児食物蛋白誘発胃腸症(新生児・乳児消化管アレルギー)
    ■6 感染症
    01 GBS感染症
    02 MRSA感染症
    03 新生児敗血症
    04 TORCH症候群
    ■7 その他、押さえておくべき疾患
    01 未熟児網膜症(ROP)
    02 新生児寒冷障害
    03 新生児薬物離脱症群
    04 多血症

    【第4章 母体疾患が胎児・新生児に与える影響】
    01 糖代謝異常合併妊娠(糖尿病合併妊娠/妊娠糖尿病)の母体より出生した児
    02 バセドウ病合併妊娠の母体より出生した児
    03 全身性エリテマトーデス合併妊娠の母体より出生した児
    04 免疫性血小板減少症(ITP)合併妊娠の母体より出生した児
    05 新型コロナウイルス感染症合併妊娠の母体より出生した児

この書籍の参考文献

参考文献のリンクは、リンク先の都合等により正しく表示されない場合がありますので、あらかじめご了承下さい。

本参考文献は電子書籍掲載内容を元にしております。

第1章 胎児・新生児の基礎知識

P.15 掲載の参考文献
1) De Paepe, ME. "Lung growth and development". Thurlbeck's pathology of the lung. 3rd ed. Chung, AM. et al eds. New York, Thieme, 2005, 39-84.
2) 長和俊. 肺サーファクタント. Neonatal Care. 21 (4), 2008, 322-30.
3) Jain, L. et al. Respiratory transition in infants delivered by cesarean section. Semin Perinatol. 30 (5), 2006, 296-304.
4) Frappell, PB. et al. Development of mechanics and pulmonary reflexes. Respir Physiol Neurobiol. 149 (1-3), 2005, 143-54.
P.21 掲載の参考文献
1) 吉田祐ほか. "心臓・血管系の発生と先天性心疾患". 新生児学テキスト. 日本新生児成育医学会編. 大阪, メディカ出版, 2018, 209-17.
2) 上田秀明. "大動脈縮窄・大動脈弓離断". 小児疾患診療のための病態生理 1. 改訂第6版. 東京, 東京医学社, 2020, 232-7.
3) 白石公. ここまで知っておきたい発生学 : 発生・形態形成の基礎知識. 日本小児循環器学会雑誌. 34 (3), 2018, 88-98.
4) 川滝元良ほか. "胎児循環から新生児循環への移行". イラストで学ぶ新生児の生理と代表的疾患. 堺武男編著. 大阪, メディカ出版, 2006, 36-8.
5) Benitz, WE. et al. "Patent ductus arteriosus". Fanaroff & Martin's Neonatal-perinatal medicine. 11th. ed. Martin, RJ. eds. Philadelphia, Elsevier, 2020, 1334-41.
6) Steinhorn, RH. "Pulmonary vascular development". Fanaroff & Martin's Neonatal-perinatal medicine. 11th. ed. Martin, RJ. eds. Philadelphia, Elsevier, 2020, 1306-19.
7) Lahm, H. et al. Congenital heart disease risk loci identified by genome-wide association study in European patients. J Clin Invest. 131 (2), 2021, e141837.
P.27 掲載の参考文献
1) Aherne, W. et al. The site of heat production in the newborn infant. Proc R Soc Med. 57 (12), 1964,1172-3.
2) Hull, D. et al. "Heat production in the newborn". Temperature regulation and energy metabolism in the newborn. Sinclair, JC, ed. New York, Grune and Stratton. 1978, 250p.
3) Hammarlund, K, et al. Transepidermal water loss in newborn infants. VIII. Relation to gestational age and post-natal age in appropriate and small for gestational age infants. Acta paediatr Scand. 72 (5), 1983, 721-8.
4) 鶴田志緒. 体温管理. with NEO. 34 (2), 2021, 234.
5) 仁志田博司. "体温調節と保温". 新生児学入門. 第5版. 仁志田博司編. 東京, 医学書院, 2018, 123-31.
6) Mullany, LC. et al. Risk of mortality associated with neonatal hypothermia in southern Nepal. Arc Pediatr Adolesc Med. 164 (7), 2010, 650-6.
7) Burnard, ED. et al. Rectal temperature in the newborn after birth asphyxia. Br Med J. 2 (5106), 1958, 1197-9.
8) Enweronu-Laryea, C. et al. Core temperature after birth in babies with neonatal encephalopathy in a sub-Saharan African hospital setting. J Physiol. 597 (15), 2019, 4013-24.
9) Tsuda, K. et al. Baby Cooling Registry of Japan Collaboration T. Body Temperature, Heart Rate, and Short-Term Outcome of Cooled Infants. Ther Hypothermia Temp Manag. 9 (1), 2019, 76-85.
10) Tsuda, K. et al. Body temperature, heart rate and long-term outcome of cooled infants : an observational study. Pediatr Res. 91 (4), 2022, 921-8.
11) Edwards, AD. Neurological outcomes at 18 months of age after moderate hypothermia for perinatal hypoxic ischaemic encephalopathy : and meta-analysis of trial data. BMJ. 340, 2010, c363.
12) Tagin, MA. et al. Hypothermia for neonatal hypoxic ischemic encephalopathy : an updated systematic review and meta-analysis. Arc Pediatr Adolesc Med.166 (6), 2012, 558-66.
P.33 掲載の参考文献
1) Garel, C. et al. Fetal cerebral cortex : normal gestational landmarks identified using prenatal MR imaging. AJNR Am J Neuroradiol. 22 (1), 2001, 184-9.
2) Penn, AA. et al. Brain waves and brain wiring : the role of endogenous and sensory-driven neural activity in development. Pediatr Res. 45 (4 Pt 1), 1999, 447-58.
3) Als, H. et al. Early experience alters brain function and structure. Pediatrics. 113 (4), 2004, 846-57.
4) 早川昌弘. "頭蓋内出血". 新生児学テキスト. 大阪, メディカ出版, 2018, 338.
5) 早川昌弘. "脳室周囲白質軟化症 (PVL)". 新生児学テキスト. 大阪, メディカ出版, 2018, 335
6) Papile, LA. et al. Incidence and evolution of subependymal and intraventricular hemorrhage : a study of infants with birth weights less than 1,500 gm. J Pediatr. 92 (4), 1978, 529-34.
7) Volpe, JJ. Brain injury in premature infants : a complex amalgam of destructive and developmental disturbances. Lancet Neurol. 8 (1), 2009, 110-24.
8) Johnson, S. et al. Early and long-term outcome of infants born extremely preterm. Arch Dis Child. 102 (2), 2017, 97-102.
9) Volpe, JJ. Encephalopathy of prematurity includes neuronal abnormalities. Pediatrics. 116 (1), 2005, 221-5.
10) Ohtaka-Maruyama, C. et al. Synaptic transmission from subplate neurons controls radial migration of neocortical neurons. Science. 360 (6386), 2018, 313-7.
11) Kidokoro, H. Delta brushes are not just a hallmark of EEG in human preterm infants. Pediatr Int. 63 (2), 2021, 130-6.
12) Maeda,T. et al. Trajectory of the incidence of brushes on preterm electroencephalogram and its association with neurodevelopment in extremely low birth weight infants. Brain Dev. 43 (10), 2021, 979-87.
P.39 掲載の参考文献
1) 安田峯生ほか訳. "消化器系". ラングマン人体発生学. 第11版. 東京, メディカル・サイエンス・インターナショナル, 2016, 233-57.
2) Schoenwolf, GC. et al. "Development of the Gastrointestinal tract". Larsen's Human Embryology. 6th. Philadelphia, Elsevier, 2021, 335-67.
3) 伊藤泰雄. "新生児 胎児・新生児の消化器の発達". 周産期医学必修知識. 第6版. 周産期医学 36巻増刊. 東京, 東京医学社, 2006, 429-30.
4) 菅沼広樹ほか. "胎児・新生児の消化器の発達 : 新生児の便". 周産期医学必修知識. 第7版. 周産期医学 41巻増刊. 東京, 東京医学社, 2011, 492-4.
5) 友滝清一. 新生児の腸内細菌叢 : その獲得と種々の病態との関連. 小児科臨床. 74 (11), 2021, 1385-9.
6) 日本小児外科学会学術・先進医療検討委員会. わが国の新生児外科の現状 : 2018年新生児外科全国集計. 日本小児外科学会雑誌. 56 (7), 2020,1167-82.
7) Yagi, M. et al. Twenty-year trends in neonatal surgery based on a nationwide Japanese surveillance program. Pediatr Surg Int. 31 (10), 2015, 955-62.
P.44 掲載の参考文献
1) 森岡一朗. "黄疸の病態と臨床". 新生児学入門. 第5版. 仁志田博司編. 東京, 医学書院, 2018, 286-304.
2) 森岡一朗. 錫メゾポルフィリンによる新生児黄疸の予防. 周産期医学. 37 (10), 2007, 1269-73.
3) 日本医療研究開発機構 (AMED) 難治性疾患実用化研究事業「早産児核黄疸の包括的診療ガイドラインの作成」班. 早産児ビリルビン脳症 (核黄疸) 診療の手引き. 2022. https://www.jpeds.or.jp/uploads/files/20200415_birirubin_tebiki.pdf [2022.6.15]
4) Onishi, S. et al. Structure and thermal interconversion of cyclobilirubin IX alpha. Biochem J. 218 (3), 1984, 667-76.

第2章 新生児の主な徴候

P.52 掲載の参考文献
1) 小田新. "エアリーク". 新生児学テキスト. 日本新生児成育医学会編. 大阪, メディカ出版, 2018, 158.
2) 山田洋輔. 喘鳴. with NEO. 32 (4), 2019, 534-43.
3) 山田洋輔. 喉頭気管支ファイバー検査. Neonatal Care. 31 (11), 2018, 1075-80.
P.59 掲載の参考文献
1) 立野滋. チアノーゼについて. 日本小児循環器学会雑誌. 31 (3), 2015, 95-101.
2) Linda S. Costanzo. "心血管系の生理学 血行力学". コスタンゾ明解生理学. 原著第6版. 林俊宏ほか監訳. 増谷聡訳. 東京, エルゼビア・ジャパン, 2019, 133-45.
3) 中川直美. チアノーゼ. 小児科診療. 80 (1), 2017, 5-12.
4) 一和多俊男. 呼吸不全の病態生理. 日本呼吸ケア・リハビリテーション学会誌. 26 (3), 2017, 422-6.
5) 増谷聡. そのファロー四徴症, 帰して大丈夫か. Neonatal Care. 31 (10), 2018, 962-6.
6) Schwartz, BN. et al. Newborn Pulse Oximetry Screening at a Community Hospital : An 8-Year Experience. Pediatrics. 148 (3), 2021, e2020049847.
7) 中野玲二ほか. パルスオキシメータによる重症先天性心疾患の出生後スクリーニングの標準化プロトコール案. 日本小児循環器学会雑誌. 36 (suppl 2), 2020, 346.
8) Ishiguro, A. et al. Randomized trial of perfusion-based circulatory management in infants of very low birth weight. J Pediatr. 243, 2022, 27-32.e2.
9) Masutani, S. et al. Successful management of the persistent pulmonary hypertension of the newborn with transposition of the great arteries by restricted patency of the ductus arteriosus : a simple and rational novel strategy. Pediatr Cardiol. 30 (7), 2009,1003-5.
P.65 掲載の参考文献
1) Christine, AG. et al. "Temperature Regulation". Avery's Diseases of the Newborn.10th ed. 東京, 南江堂, 2018, 361-7.
2) Sonoda, M. et al. Prognostic factors for survival of herpes simplex virus-associated hemophagocytic lymphohistiocytosis. Int J Hematol. 111 (1), 2020, 131-6.
3) Laptook, AR. et al. Admission temperature of low birth weight infants : predictors and associated morbidities. Pediatrics. 119 (3), 2007, e643-9.
4) 細野茂春監. 日本版救急蘇生ガイドライン2020に基づく : 新生児蘇生法テキスト. 第4版. 東京, メジカルビュー社, 2021, 204p.
P.72 掲載の参考文献
1) Murray, DM. et al. Defining the gap between electrographic seizure burden, clinical expression and staff recognition of neonatal seizures. Arch Dis Child Fetal Neonatal Ed. 93 (3), 2008, F187-91.
3) Glass, HC. et al. Contemporary profile of seizures in neonates : a prospective cohort study. J Pediatr. 174, 2016, 98-103.
4) Nash, KB. et al. Video-EEG monitoring in newborns with hypoxic-ischemic encephalopathy treated with hypothermia. Neurology. 76 (6), 2011, 556-62.
5) Pressler, RM. et al. The ILAE classification of seizures and the epilepsies : Modification for seizures in the neonate. Position paper by the ILAE Task Force on Neonatal Seizures. Epilepsia. 62 (3), 2021, 615-28.
6) Kubota, T. et al. Evaluation of interobserver variability in application of the new neonatal seizure classification proposed by the ILAE Task Force. Epilepsy Behav. 111, 2020, 107292.
7) 奥村彰久ほか編, "新生児発作". 新 誰でも読める新生児脳波. 東京, 診断と治療社, 2019, 160-74.
8) Pinchefsky, EF. et al. Outcomes following electrographic seizures and electrographic status epilepticus in the pediatric and neonatal ICUs. Curr Opin Neurol. 30 (2), 2017, 156-64.
9) Soul, JS. et al. Recommendations for the design of therapeutic trials for neonatal seizures. Pediatr Res. 85 (7), 2019, 943-54.
P.80 掲載の参考文献
1) 東海林宏道ほか. 新生児期の嘔吐の原因と診断・管理手順. 小児内科. 43 (12), 2011, 1977-80.
2) 川瀬泰浩. 新生児の吐血・嘔吐, 排便異常. 産婦人科治療. 97 (6), 2008, 567-72.
P.88 掲載の参考文献
1) Van Praagh, R. Diagnosis of kernicterus in the neonatal period. Pediatrics. 28, 1961, 870-6.
2) 森岡一朗ほか. 早産児の黄疸管理 : 新しい管理方法と治療基準の考案. 日本周産期・新生児医学会雑誌. 53 (1), 2017, 1-9.
3) 阿部真也ほか. "黄疸計の使い方と光線療法". 新生児医療67 の臨床手技とケア タイミング : 流れ & コツ, 評価まで見える. with NEO 秋季増刊. with NEO 編集委員会編. 大阪, メディカ出版, 2019, 254-60.
4) Abe, S. et al. Can exchange transfusion be replaced by double-LED phototherapy?. Open Med (Wars). 16 (1), 2021, 992-6.
P.95 掲載の参考文献
1) 中西秀彦. not doing well. Neonatal Care. 29 (4), 2016, 355-60.
2) 福原里恵. "退院まで : not doing wellのアセスメント". 日本新生児成育医学会編, 新生児学テキスト. 大阪, メディカ出版, 2018, 812-6
3) 斎藤誠. "not doing well". 新生児の症状別フィジカルアセスメント. Neonatal Care 春季増刊. 大木茂編. 大阪, メディカ出版, 2015, 227-32.
4) Geggel, R L. Diagnosis and initial management of cyanotic heart disease in the newborn. Hyperoxia test. https://www.uptodate.com/contents/diagnosis-and-initial-management-of-cyanotic-heart-disease-in-the-newborn?search=%20hyperoxgen%20test&source=search_result&selectedTitle=1~11&usage_type=default&display_rank=1 [2022. 6.8]

第3章 新生児の代表的疾患

P.105 掲載の参考文献
1) Kliegman, RM. et al. "Apnea". Nelson Textbook of Pediatrics. 21st ed. Philadelphia, ELSVIER, 2020, 122.
2) Eichenwald, EC. et al. Apnea of Prematurity. Pediatrics. 137 (1), 2016, doi : 10.1542/peds.2015-3757.
3) 滝敦子ほか. 未熟児無呼吸発作. Neonatal Care. 19 (5), 2006, 423-9.
4) 川崎裕香子. 新生児無呼吸発作. Neonatal Care. 31 (9), 2018, 832-8.
5) 細野茂春. 日本版救急蘇生ガイドライン2020に基づく 新生児蘇生法テキスト. 第4版. 東京, メジカルビュー社, 2021, 204p.
6) ドプラム(R). インタビューフォーム. 2020年7月 (改定第6版).
7) Park, HW. et al. Early caffeine use in very low birth weight infants and neonatal outcomes : a systematic review and meta-analysis. J Korean Med Sci. 30 (12), 2015, 1828-35.
8) Lodha, A. et al. Early caffeine administration and neurodevelopmental outcomes in preterm Infants. Pediatrics. 143 (1), 2019, e20181348.
P.113 掲載の参考文献
1) Tammela, O. "Diseases and Disorders, General : Respiratory distress syndrome". Gomella's Neonatology 8th ed. New York, MCGRAW-HILL EDUCATION, 2020, 1043-50.
2) Jobe, AH. et al. Decreased indicators of lung injury with continuous positive expiratory pressure in preterm lambs. Pediatr Res. 52 (3), 2002, 387-92.
3) Bohlin, K. et al. Implementation of surfactant treatment during continuous positive airway pressure. J Perinatol. 27 (7), 2007, 422-7.
4) Kandraju, H. et al. Early routine versus late selective surfactant in preterm neonates with respiratory distress syndrome on nasal continuous positive airway pressure : a randomized controlled trial. Neonatology,103 (2), 2013, 148-54.
5) Papile LA. et al. Respiratory support in preterm infants at birth. Pediatrics. 133 (1), 2014,171-4.
6) 大曽根義輝. "サーファクタント補充療法". 周産期医学 必修知識. 第9版. 楠田聡ほか編. 東京, 東京医学社, 2022, 1124-6.
7) Szczapa, T. et al. Implementation of less invasive surfactant administration in clinical practice-Experience of a mid-sized country. PLoS One. 15 (7), 2020, e0235363.
8) Bianco, F. et al. Aerosol drug delivery to spontaneously-breathing preterm neonates : lessons learned. Respir Res. 22 (1), 2021, 71.
9) Beltempo, M. et al. Respiratory management of extremely preterm infants : an international survey. Neonatology. 114 (1), 2018, 28-36.
P.117 掲載の参考文献
1) 仁志田博司. "肺水の動態と一過性多呼吸". 新生児学入門. 第5版. 仁志田博司編. 東京, 医学書院. 2018, 155-60.
P.127 掲載の参考文献
1) Thornton, PD. et al. Meconium aspiration syndrome : Incidence and outcomes using discharge data. Early Hum Dev. 136, 2019, 21-6.
2) Balchin, I. et al. Maternal and fetal characteristics associated with meconium-stained amniotic fluid. Obstet Gynecol. 117 (4), 2011, 828-35.
3) Lee, KA. et al. The frequency of meconium-stained amniotic fluid increases as a function of the duration of labor. J Matern Fetal Neonatal Med. 24 (7), 2011, 880-5.
4) Lee, J. et al. Meconium aspiration syndrome : a role for fetal systemic inflammation. Am J Obstet Gynecol. 214 (3), 2016, 366.
5) 日本産科婦人科学会/日本産婦人科医会. "CQ407 羊水混濁時の対応は? ". 産婦人科診療ガイドライン : 産科編 2020. 東京, 日本産科婦人科学会, 2020, 214-6.
6) Autilio, C. et al. Surfactant injury in the early phase of severe meconium aspiration syndrome. Am J Respir Cell Mol Biol. 63 (3), 2020, 327-37.
7) Dehan, M. et al. Diagnosis of meconium aspiration by spectrophotometric analysis of urine. Arch Dis Child. 53 (1), 1978, 74-6.
8) 成瀬寛夫ほか. 蛍光を用いた胎便吸引症候群 (MAS) の特異的診断法に関する研究. 日本産科婦人科学会雑誌. 428 (7) 1990, 719-26.
9) Rawat, M. et al. Optimal oxygen targets in term lambs with meconium aspiration syndrome and pulmonary hypertension. Am J Respir Cell Mol Biol. 63 (4), 2020, 510-8.
10) Mercier, JC, et al. Disease-related response to inhaled nitric oxide in newborns with severe hypoxaemic respiratory failure. French Paediatric Study Group of Inhaled NO. Eur J Pediatr. 157 (9), 1998, 747-52.
11) Stranak, Z. et al. Changes in alveolar-arterial oxygen difference and oxygenation index during low-dose nitric oxide inhalation in 15 newborns with severe respiratory insufficiency. Eur J Pediatr. 155 (10), 1996, 907-10.
12) Hahn, S. et al. Lung lavage for meconium aspiration syndrome in newborn infants. Cochrane Database Syst Rev. (4), 2013, CD003486.
13) El Shahed, AI. et al. Surfactant for meconium aspiration syndrome in term and late preterm infants. Cochrane Database Syst Rev. 2014 (12). 2014, CD002054.
14) Ward, M. et al. Steroid therapy for meconium aspiration syndrome in newborn infants. Cochrane Database Syst Rev. 2003 (4), 2003, CD003485.
P.135 掲載の参考文献
1) 新井浩和. 日本の慢性肺疾患分類がもつ問題点とその可能性. 日本新生児成育医学会雑誌. 32 (2), 2020, 285-9.
2) 諫山哲也. 世界における慢性肺疾患の定義の変遷と現状. 日本新生児成育医学会雑誌. 32 (2), 2020, 264-8.
3) Nakashima, T. et al. Trends in bronchopulmonary dysplasia among extremely preterm infants in Japan, 2003-2016. J Pediatr. 230, 2021, 119-25.
4) 大内玲. 人工呼吸器との非同調のなおし方 : 非同調と向き合い,快適性を向上させるために. ICNR.7 (4), 2020, 27-35.
5) Gilfillan, M. et al. Diagnosis and management of bronchopulmonary dysplasia. BMJ. 2021, 375, n1974.
6) 岸上真ほか. "呼吸窮迫症候群 (RDS), 慢性肺疾患 (CLD)". 病態・疾患別でまなぶ 新生児の薬剤. Neonatal Care 秋季増刊. 大阪, メディカ出版, 2018, 50-62.
7) Watterberg, KL. et al. Hydrocortisone to improve survival without bronchopulmonary dysplasia. N Engl J Med. 386 (12), 2022, 1121-31.
8) Abman, SH. Interdisciplinary care of children with severe bronchopulmonary dysplasia. J Pediatr. 181, 2017, 12-28.
9) Cheong, JL. et al. An update on pulmonary and neurodevelopmental outcomes of bronchopulmonary dysplasia. Semin perinatal. 42 (7), 2018, 478-84.
10) Arai, H. Impact of chest radiography-based definition of bronchopulmonary dysplasia. Pediatr Int. 61 (3), 2019, 258-63.
P.141 掲載の参考文献
1) 山本裕. 未熟児動脈管開存症. Neonatal Care. 23 (5), 2010, 462-9.
2) 山本裕. 未熟児動脈管開存症 (PDA) を知ろう. Neonatal Care. 29 (8), 2016, 700-3.
3) Kumar, J. et al. Platelet transfusion for PDA closure in preterm infants : a randomized controlled trial. Pediatrics. 143 (5), 2019, e20182565.
4) El-Mashad, AE. et al. Comparative study of the efficacy and safety of paracetamol, ibuprofen, and indomethacin in closure of patent ductus arteriosus in preterm neonates. Eur J Pediatr. 176 (2), 2017, 233-40.
6) Bell, EF. et al. Restricted versus liberal water intake for preventing morbidity and mortality in preterm infants. Cochrane Database Syst Rev. 2014 (12), 2014, CD000503.
7) 難波文彦. 未熟児動脈管開存症に対するアセトアミノフェン静注療法の安全性及び有効性に関する多施設共同ランダム化比較試験研究計画書. 第1版. http://www.jspnm.com/topics/data/kaiin20220420.pdf [2022.6.22]
8) 日本未熟児新生児学会・標準化検討委員会 J-PrePガイドライン作成チーム. 根拠と総意に基づく未熟児動脈管開存症治療ガイドライン. 日本未熟児新生児学会雑誌. 22 (2), 2010, 77-89.
9) Mitra, S. et al. Prophylactic cyclo-oxygenase inhibitor drugs for the prevention of morbidity and mortality in preterm infants : a network meta-analysis. Cochrane Database Syst Rev. 4 (4), 2022, CD013846.
10) Mitra, S. et al. Association of placebo, indomethacin, ibuprofen, and acetaminophen with closure of hemodynamically significant patent ductus arteriosus in preterm infants : a systematic review and meta-analysis. JAMA. 319 (12), 2018, 1221-38.
11) Malviya, MN. et al. Surgical versus medical treatment with cyclooxygenase inhibitors for symptomatic patent ductus arteriosus in preterm infants. Cochrane Database Syst Rev. 2013 (3), 2013, CD003951.
P.147 掲載の参考文献
1) 河井昌彦. "早産児の循環不全に対するステロイド療法". 新版 新生児内分泌ハンドブック. 新生児内分泌研究会編著. 大阪, メディカ出版, 2020, 237-43.
2) 中西秀彦. "晩期循環不全". 周産期診療指針 2010. 周産期医学編集委員会編. 東京, 東京医学社, 2011, 701-3.
3) Suzuki, Y. et al. Neonatal factors related to center variation in the incidence of late-onset circulatory collapse in extremely preterm infants. PLoS One. 13 (6), 2018, e0198518.
5) Kawai, M. Late-onset circulatory of collapse of prematurity. Pediatr Int. 59 (4), 2017, 391-6.
8) Shimokaze, T. et al. Increased incidence of late-onset circulatory collapse after changing clinical practice : a retrospective investigation of causative factors. Am J Perinatol. 32 (12), 2015, 1169-76.
10) Marinelli, KC. et al. Clinical risk factors for the development of late-onset circulatory collapse in premature infants. Pediatr Res. 89 (4), 2021, 968-73.
11) Okamura, T. et al. Association between eosinophilia and late-onset circulatory collapse in preterm infants : a case-control study. Acta Med Okayama. 75 (4), 2021, 505-9.
P.153 掲載の参考文献
1) Jain, A. et al. Persistent pulmonary hypertension of the newborn : advances in diagnosis and treatment. Semin Fetal Neonatal Med. 20 (4), 2015, 262-71.
2) Walsh-Sukys, MC. et al. Persistent pulmonary hypertension of the newborn in the era before nitric oxide : practice variation and outcomes. Pediatrics. 105 (1 Pt 1), 2000, 14-20.
3) Nakwan, N. et al. An Asian multicenter retrospective study on persistent pulmonary hypertension of the newborn : incidence, etiology, diagnosis, treatment and outcome. J Matern Fetal Neonatal Med. 33 (12), 2020, 2032-7.
4) Nakanishi, H. et al. Persistent pulmonary hypertension of the newborn in extremely preterm infants : a Japanese cohort study. Arch Dis Child Fetal Neonatal Ed. 103 (6), 2018, F554-61.
5) 後藤彰子. "周生期特有の循環器病態". 臨床発達心臓病学. 改訂3版. 高尾篤良ほか編. 東京, 中外医学社, 2001, 84-92.
6) Bendapudi P, et al. Diagnosis and management of persistent pulmonary hypertension of the newborn. Paediatr Respir Rev. 16 (3), 2015, 157-61.
7) 石戸博隆. "新生児遷延性肺高血圧症". 小児・成育循環器学. 日本小児循環器学会編. 東京, 診断と治療社, 2018, 344-6.
8) Steurer, MA. et al. Morbidity of Persistent Pulmonary Hypertension of the Newborn in the First Year of Life. J Pediatr. 213, 2019, 58-65.e4.
9) Konduri, GG. et al. Early inhaled nitric oxide therapy for term and near-term newborn infants with hypoxic respiratory failure : neurodevelopmental follow-up. J Pediatr.150 (3), 2007, 235-40, 40.e1.
10) Shiraishi, J. et al. Standardization of nitric oxide inhalation in extremely preterm infants in Japan. Pediatr Int. 61 (2), 2019, 152-7.
P.163 掲載の参考文献
1) 市田蕗子. 先天性心疾患の疫学. 日本小児循環器学会雑誌. 26 (1), 2010, 2-3.
2) 松岡瑠美子ほか. 先天性心血管疾患の疫学調査 : 1990年4月-1999年7月, 2,654家系の報告. 日本小児循環器学会雑誌. 19 (6), 2003, 606-21.
3) 高尾篤良. 臨床発達心臓病学. 改訂3版. 東京, 中外医学社, 2001, 939p.
4) Holland, BJ. et al. Prenatal diagnosis of critical congenital heart disease reduces risk of death from cardiovascular compromise prior to planned neonatal cardiac surgery : a meta-analysis. Ultrasound Obstet Gynecol. 45 (6), 2015, 631-8.
5) Colaco, SM. et al. Neonates with critical congenital heart defects : Impact of fetal diagnosis on immediate and short-term outcomes. Ann Pediatric Cardiol. 10 (2), 2017, 126-30.
6) 榎本淳子ほか. 成人先天性心疾患患者の就業状況とその背景要因. 日本小児循環器学会雑誌. 35 (1), 2019, 18-26.
7) Spector, LG. et al. Trends in Long-Term Mortality After Congenital Heart Surgery. J Am Coll Cardiol. 71 (21), 2018, 2434-46.
8) Best, KE. et al. The Improved Prognosis of Hypoplastic Left Heart : A Population-Based Register Study of 343 Cases in England and Wales. Frontiers Pediatrics. 9, 2021, doi : 10. 3389/fped. 2021. 635776.
P.170 掲載の参考文献
1) Inder, T. et al. "Intraventricular hemorrhage in the neonate". Fetal and Neonatal Physiology. 4th ed. Richard, A. et al. eds. Philadelphia, Saunders, 2011, 1831-47.
2) Mohamed, MA. et al. Transport of premature infants is associated with increased risk for intraventricular haemorrhage. Arch Dis Child Fetal Neonatal Ed. 95 (6), 2010, F403-7.
3) Lea, CL. et al. Protecting the premature brain : current evidence-based strategies for minimising perinatal brain injury in preterm infants. Arch Dis Child Fetal Neonatal Ed. 102 (2), 2017, F176-82.
P.175 掲載の参考文献
1) 川瀬恒哉ほか. "脳室周囲白質軟化症 (PVL)". 新生児の代表的疾患と病態生理マスターブック. 大木茂編. Neonatal Care 春季増刊. 大阪, メディカ出版, 2017, 124.
2) Banker, BQ. et al. Periventricular leukomalacia of infancy. A form of neonatal anoxic encephalopathy. Arch Neurol. 7, 1962, 386-410.
3) Volpe, JJ. Confusions in Nomenclature : "Periventricular leukomalacia" and "white matter injury" -identical, distinct, or overlapping? Pediatr Neurol. 73, 2017, 3-6.
4) Volpe, JJ. Brain injury in premature infants : a complex amalgam of destructive and developmental disturbances. Lancet Neurol. 8 (1), 2009, 110-24.
5) Sugiura, T. et al. Periventricular leukomalacia is decreasing in Japan. Pediatr Neurol. 47 (1), 2012, 35-9.
6) Tusor, N. et al. Punctate white matter lesions associated with altered brain development and adverse motor outcome in preterm infants. Sci Rep. 7 (1), 2017, 13250.
7) Wagenaar, N. et al. Clinical risk factors for punctate white matter lesions on early magnetic resonance imaging in preterm newborns. J Pediatr. 182, 2017, 34-40.e1.
8) Fischer, HS. et al. Prophylactic early erythropoietin for neuroprotection in preterm infants : a meta-analysis. Pediatrics. 139 (5), 2017, e20164317.
9) Juul, SE. et al. PENUT trial consortium. a randomized trial of erythropoietin for neuroprotection in preterm infants. N Engl J Med. 382 (3), 2020, 233-43.
P.182 掲載の参考文献
1) Takenouchi, T. et. al.Therapeutic hypothermia for neonatal encephalopathy : JSPNM & MHLW Japan Working Group Practice Guidelines Consensus Statement from the Working Group on Therapeutic Hypothermia for Neonatal Encephalopathy, Ministry of Health, Labor and Welfare (MHLW), Japan, and Japan Society for Perinatal and Neonatal Medicine (JSPNM). Brain Dev. 34 (2), 2012, 165-70.
2) 田村正徳ほか. 2015CoSTR に基づいた 新生児低体温療法実践マニュアル. 岩田欧介編. 東京, 東京医学社, 2016, 231p.
3) 鍋谷まことほか. "低体温療法". 周産期医学. 第9版. 周産期医学 51巻増刊. 東京, 東京医学社, 2021, 1087-91.
4) 新宅治夫. 自己臍帯血幹細胞治療. 周産期医学. 46 (8), 2016, 1031-3.
5) 長谷川昌文. エリスロポエチン大量療法. 周産期医学. 46 (8), 2016, 1035-38.
6) 加藤稲子. 新生児仮死による脳性麻痺に対する臍帯血幹細胞治療・エリスロポエチンの効果. 周産期医学. 46 (11), 2016, 1415-19.
7) Fukuda, S. et al. Experience of cases with inhaled nitric oxide and therapeutic hypothermia. Pediatr Int. 64 (1), 2022, e14901.
P.189 掲載の参考文献
1) NPO法人新生児臨床研究ネットワーク. 周産期母子医療センターネットワークデータベース解析報告. http://plaza.umin.ac.jp/nrndata/[2022. 6.1]
2) Kliegman, RM. et al. Neonatal necrotizing enterocolitis : pathogenesis, classification, and spectrum of illness. Curr probl pediatr. 17 (4), 1987, 213-88.
4) Altobelli, E. et al. The Impact of Human Milk on Necrotizing Enterocolitis : a systematic review and meta-analysis. Nutrients. 12 (5), 2020, 1322.
5) Fisher, JG. et al. Mortality associated with laparotomy-confirmed neonatal spontaneous intestinal perforation : a prospective 5-year multicenter analysis. J Pediatr Surg. 49 (8), 2014, 1215-9.
6) Chi, C. et al. Effects of Probiotics in Preterm Infants : a Network Meta-analysis. Pediatrics. 147 (1), 2021, e20200706.
7) 久田研. 正期産児, 早産児の腸内細菌叢の生後変化. 周産期医学 50 (3). 2020. 337-41.
8) Denning, NL. et al. Neonatal intestinal dysbiosis in necrotizing enterocolitis. Mol Med, 24 (1), 2018, 4.
9) Satoh, T. et al. Bifidobacterium breve prevents necrotising enterocolitis by suppressing inflammatory responses in a preterm rat model. Benef Microbes. 7 (1), 2016, 75-82.
10) Wang, K. et al. Recent Advances in Prevention and Therapies for Clinical or Experimental Necrotizing Enterocolitis. Dig Dis Sci. 64 (11), 2019, 3078-85.
P.195 掲載の参考文献
1) 最新NICU マニュアル. 改訂第6版. 細井創監. 徳田幸子編. 東京, 診断と治療社, 2017, 240p.
2) 宮沢篤生. "胎便関連性腸閉塞症". 新生児学テキスト. 日本新生児成育医学会編. 大阪, メディカ出版, 2018, 395-7.
3) Kim, HY et al. Meconium-related ileus in very low birth weight and extremely low birth weight infants : immediate and one-year postoperative outcomes. Ann Surg Treat Res. 89 (3), 2015, 151-7.
4) 丸山憲一. "胎便病". 新生児の疾患・治療・ケア. 最新2版. 楠田聡監. 大阪, メディカ出版, 2016, 98-101.
5) Gleason, CA. et al. Avery's Diseases of the Newborn. 10th ed. Philadelphia, ELSEVIER, 2018, 1627p.
6) 窪田昭男ほか. 周産期センターにおける胎便関連性腸閉塞症例の検討. 日本新生児学会雑誌. 31 (1), 1995, 120-7.
P.203 掲載の参考文献
1) Le Bret, E. et al. Slide tracheoplasty in infant with congenital tracheal stenosis and tracheomalacia after esophageal atresia with tracheoesophageal fistula repair. J Pediatr Surg. 44 (7), 2009, e15-7.
2) Ratan, SK. Laryngotracheo-esophageal cleft in a neonate with esophageal atresia and tracheo-esophageal fistula : report of a case. Surg Today. 31 (1), 2001. 59-61.
3) Krishnamurthy, K. et al. Tracheal agenesis with esophageal atresia : an autopsy case report of a variant incompatible with life. Fetal Pediatr Pathol. 39 (1), 2020. 39 (1), 45-50.
4) Harumatsu T, Kaji T, Nagano A, Matsui M, Murakami M, Sugita K, Matsukubo M and Ieiri S. Successful thoracoscopic treatment for tracheoesophageal fistula and esophageal atresia of communicating bronchopulmonary foregut malformation group IB with dextrocardia : a case report of VACTERL association. Surg Case Rep. 2021 ; 7 : 11.
5) Okuyama H, Kubota A, Kawahara H, Oue T and Tazuke Y. Congenital laryngeal atresia associated with esophageal atresia and tracheoesophageal fistula : a case of long-term survival. J Pediatr Surg. 2006 ; 41 : e29-32.
6) Pardy C, D'Antonio F, Khalil A and Giuliani S. Prenatal detection of esophageal atresia : A systematic review and meta-analysis. Acta Obstet Gynecol Scand. 2019 ; 98 : 689-699.
7) Foker JE, Linden BC, Boyle EM, Jr. and Marquardt C. Development of a true primary repair for the full spectrum of esophageal atresia. Ann Surg. 1997 ; 226 : 533-41 ; discussion 541-3.
8) Mochizuki K, Obatake M, Taura Y, Inamura Y, Kinoshita A, Fukuda A, Kosaka T, Takatsuki M, Nagayasu T and Eguchi S. A modified Foker's technique for long gap esophageal atresia. Pediatr Surg Int. 2012 ; 28 : 851-4.
9) Way C, Wayne C, Grandpierre V, Harrison BJ, Travis N and Nasr A. Thoracoscopy vs. thoracotomy for the repair of esophageal atresia and tracheoesophageal fistula : a systematic review and meta-analysis. Pediatr Surg Int. 2019 ; 35 : 1167-1184.
10) Capitanio M, Guana R, Garofalo S, Scottoni F, Cortese MG, Marchetti C and Gennari F. Quality of life and long-term results in patients operated on for Esophageal Atresia. Minerva Pediatr (Torino). 2021.
P.208 掲載の参考文献
1) 先天性難治性稀少泌尿生殖器疾患群 (総排泄腔遺残, 総排泄腔外反, MRKH 症候群) におけるスムーズな成人期医療移行のための分類・診断・治療ガイドライン. 先天性難治性稀少泌尿生殖器疾患群 (総排泄腔遺残, 総排泄腔外反, MRKH症候群) におけるスムーズな成人期医療移行のための分類・診断・治療ガイドライン作成研究班編. 東京, メジカルビュー社, 2017, 112p.
2) Kubota, M. The current profile of persistent cloaca and cloacal exstrophy in Japan : the results of a nationwide survey in 2014 and a review of the literature. Pediatr Surg Int 2017, 33 (4), 505-12.
P.214 掲載の参考文献
1) 日本小児外科学会学術・先進医療検討委員会. わが国の新生児外科の現状 : 2018 年新生児外科全国集計. 日小外会誌. 56 (7), 2020, 1167-82.
2) 上野滋. "腸回転異常症". 標準小児外科学. 第7版. 高松英夫ほか監. 東京, 医学書院, 2017, 179-82.
P.220 掲載の参考文献
1) Cantrell, JR. et al. A syndrome of congenital defects involving the abdominal wall, sternum, diaphragm, pericardium, and heart. Surg Gynecol Obstet. 107 (5), 1958, 602-14.
2) 日本小児外科学会学術・先進医療検討委員会. わが国の新生児外科の現状 : 2013年新生児外科全国集計. 日本小児外科学会雑誌. 51 (7), 2015, 1234-45.
3) 渡辺健太郎ほか. 腹壁破裂に対するsutureless 腹壁閉鎖法とその治療成績 : 従来法との比較. 日本小児外科学会雑誌. 47 (7), 2011, 998-1003.
4) van Eijck, FC. et al. Closure of giant omphaloceles by the abdominal wall components separation technique in infants. J Pediatr Surg. 43 (1), 2008, 246-50.
5) 坂井幸子ほか. 創傷被覆保護材を用いて臍帯を上皮化しcomponents separation techniqueにて腹壁閉鎖を行った巨大臍帯ヘルニアの1例. 日本小児外科学会雑誌. 52 (4), 2016, 970-6.
P.225 掲載の参考文献
1) 河井昌彦. 新生児期の低血糖症の病態生理. 日本新生児成育医学会雑誌. 31 (2), 2019, 333-5.
2) Committee on Fetus and Newborn. et al. Postnatal glucose homeostasis in late-preterm and term infants. Pediatrcs. 127 (3), 2011, 575-9.
3) Thornton, PS. et al. Recommendations form the Pediaric Endocrine Society for Evaluation and Management of Persistent hypoglycemia in neonates, infants, and children. J Pediatr. 167 (2), 2015, 238-45.
4) 河井昌彦. 血糖値. with NEO. 32 (5), 2019, 644-50.
P.232 掲載の参考文献
1) 米谷昌彦ほか. "新生児の黄疸". 白木和夫ほか編. 小児科学. 東京, 医学書院, 1997, 433.
2) 日本医療研究開発機構 (AMED) 難治性疾患実用化研究事業 「早産児核黄疸の包括的診療ガイドラインの作成」班. 早産児ビリルビン脳症 (核黄疸) 診療の手引き. chrome-extension://efaidnbmnnnibpcajpcglclefindmkaj/https://www.jpeds.or.jp/uploads/files/20200415_birirubin_tebiki.pdf [2022. 6. 3]
P.237 掲載の参考文献
1) 河井昌彦. NICU ベッドサイドの診断と治療. 第4版. 京都, 金芳堂, 2016, 270-5.
2) Motokura, K. et al. Appropriate Phosphorus Intake by Parenteral Nutrition Prevents Metabolic Bone Disease of Prematurity in Extremely Low-Birth-Weight Infants. JPEN J Parenter Enteral Nutr. 45 (6), 2021, 1319-26.
3) Saggese, G. et al. Vitamin D in pediatric age : consensus of the Italian Pediatric Society and the Italian Society of Preventive and Social Pediatrics, jointly with the Italian Federation of Pediatricians. Ital J Pediatr. 44 (1), 2018, 51.
P.244 掲載の参考文献
1) Yamada, Y. Unique features of non-IgE-mediated gastrointestinal food allergy during infancy in Japan. Curr Opin Allergy Clin Immunol. 20 (3), 2020, 299-304.
2) Nomura, I. et al. Four distinct subtypes of non-IgE-mediated gastrointestinal food allergies in neonates and infants, distinguished by their initial symptoms. J Allergy Clin Immunol. 127 (3), 2011, 685-8. e1-8.
3) Miyazawa, T. et al. Management of neonatal cow's milk allergy in high-risk neonates. Pediatr Int. 51 (4), 2009, 544-7.
4) 山田佳之. 新生児・乳児食物蛋白誘発胃腸症 (新生児・乳児消化管アレルギー). with NEO, 34 (3), 2021, 374-82.
5) Kimura, M. et al. Increased C-reactive protein and fever in Japanese infants with food protein-induced enterocolitis syndrome. Pediatr Int. 58 (9), 2016, 826-30.
6) 厚生労働省好酸球性消化管疾患研究班ほか. 新生児・乳児食物蛋白誘発胃腸症診療ガイドライン (実用版). 2019. https://minds.jcqhc.or.jp/docs/gl_pdf/G0001047/4/non-IgE-mediated_gastrointestinal-food-allergy.pdf [2022.6.22]
7) Nowak-Wegrzyn, A. et al. International consensus guidelines for the diagnosis and management of food protein-induced enterocolitis syndrome : executive summary-workgroup report of the adverse reactions to Foods Committee, American Academy of Allergy, Asthma & Immunology. J Allergy Clin Immunol. 139 (4), 2017, 1111-26.e4.
8) Kimura, M. et al. Close positive correlation between the lymphocyte response to hen egg white and house dust mites in infants with atopic dermatitis. Int Arch Allergy Immunol. 166 (3), 2015, 161-9.
9) Arvola, T. et al. Rectal bleeding in infancy : clinical, allergological, and microbiological examination. Pediatrics. 117 (4), 2006, e760-8.
10) Toyama, Y. et al. Multicenter retrospective study of patients with food protein-induced enterocolitis syndrome provoked by hen's egg. J Allergy Clin Immunol Pract. 9 (1), 2021, 547-9. e1.
P.249 掲載の参考文献
1) Matsubara, K. et al. Group B streptococcal disease in infants in the first year of life : a nationwide surveillance study in Japan, 2011-2015. Infection. 45 (4), 2017, 449-58.
2) 笠井正志ほか. 本邦複数の小児医療施設における血液培養採取量と検出率に関する観察研究. 感染症学雑誌. 87 (5), 2013, 620-3.
3) 日本産科婦人科学会/日本産婦人科医会. "CQ603 正期産新生児の早発型B群溶血性レンサ球菌 (GBS) 感染症を予防するためには?". 産婦人科診療ガイドライン : 産科編 2020. 東京, 日本産科婦人科学会. 2020, 297-9.
4) 松原康策. 新生児・乳児のB群レンサ球菌感染症の現状. チャイルド ヘルス. 21 (5), 2018, 363-5.
P.257 掲載の参考文献
1) Usukura, Y, et al. Examination of severe, hospital acquired infections affecting extremely low birth weight (ELBW) infants. Pediantr Int. 45 (2), 2003, 230-2.
2) Takahashi, N. et al. Exanthematous disease induced by toxic shock syndrome toxin 1 in the early neonatal period. Lancet. 351 (9116), 1998, 1614-19.
3) Takahashi, N. et al. Clinical features of neonatal toxic shock syndrome-like exanthematous disease emerging in Japan. J Infect. 59 (3), 2009, 194-200.
4) Kikuchi, K. et al. Molecular epidemiology of methicillin-resistant Staphylococcus aureus strains causing neonatal toxic shock syndrome-like exanthematous disease in neonatal and perinatal wards. J Clin Microbiol. 41 (7), 2003, 3001-6.
5) Takahashi, N. et al. Change of specific T cells in an emerging neonatal infectious disease induced by a bacterial superantigen. Microbiol Immunol. 53 (9), 2009, 524-30.
6) 高橋尚人ほか. 新生児集中治療室におけるMRSA保菌に関する全国調査. 日本小児科学会雑誌. 109 (8), 2005, 1009-14.
7) Morioka, I. et al. Prevalence of MRSA colonization in Japanese neonatal care unit patients in 2011. Pediatr Int. 2014, 56 (2), 211-4.
8) 大城誠ほか. 極低出生体重児における感染症に関する全国調査 : 2000年と2010年出生児の比較. 日本未熟児新生児学会雑誌. 26 (1), 2014, 99-104.
9) 青柳順ほか. 当院NICUにおける速乾性擦式消毒剤個人携帯とmupirocin非選択的全例塗布によるMRSA保菌抑制の試み. 日本周産期・新生児医学会雑誌. 44 (4), 2008, 1147-51.
10) 高橋尚人. "新生児TSS様発疹症 (NTED)". 感染症症候群. 第2版 (下). 日本臨牀別冊. 東京, 日本臨牀社, 2013, 17-20.
P.263 掲載の参考文献
1) Stoll, BJ. et al. Early onset neonatal sepsis : the burden of group B streptococcal and E. coli disease continues. Pediatrics. 127 (5), 2011, 817-26.
2) Vergnano, S. et al. Neonatal infections in England : the NeonIN surveillance network. Arch Dis Child Fetal Neonatal Ed. 96 (1), 2011, F9-14.
3) Singh, T. et al. Early-onset neonatal infections in Australia and New Zealand, 2002-2012. Arch Dis Child Fetal Neonatal Ed. 104 (3), 2019, F248-252.
4) Giannoni, E. et al. Neonatal sepsis of early onset, and hospital-acquired and community-acquired late onset : a prospective population-based cohort study. J Pediatr. 201, 2018, 106-14. e4.
5) Gudjonsdottir, MJ. et al. Changes in incidence and etiology of early-onset neonatal infections 1997-2017 - a retrospective cohort study in western Sweden. BMC Pediatr. 19 (1), 2019, 490.
6) Berardi, A. et al. Epidemiology and complications of late- onset sepsis : an Italian area-based study. PLoS One. 14 (11), 2019, e0225407.
7) Puopolo, KM. et al. Management of Neonates Born at < 34 6/7 weeks' gestation With suspected or Proven Early-onset Bacterial Sepsis. Pediatrics. 142 (6), 2018, e20182896.
8) Schmatz, M. et al. Surviving Sepsis in a Referral Neonatal Intensive Care Unit : Association between Time to Antibiotic Administration and In-Hospital Outcomes. J Pediatr. 217, 2020, 59-65. e1.
9) Achten, NB. et al. Association of Use of the Neonatal Early-Onset Sepsis Calculator With Reduction in Antibiotic Therapy and Safety : A systematic Review and Meta-analysis. JAMA Pediatr. 173 (11), 2019, 1032-40.
10) Fleiss, N. et al. Evaluation of the Neonatal Sequential Organ Failure Assessment and Mortality Risk in Preterm Infants With Late-Onset Infection. JAMA Netw Open. 4 (2), 2021, e2036518.
P.276 掲載の参考文献
1) Sato, T. et al. "Type I interfereonopathies : Common pathological features between congenital infections and genetic disorders". Human Pathobiochemistry : From clinical studies to molecular mechanisms. Oohashi T, et al. eds. Berlin, Springer, 2019, 279-94.
2) 森内浩幸. "胎内感染症 (TORCH)". 小児感染免疫学. 日本小児感染症学会編. 東京, 朝倉書店, 2020, 456-77.
3) Imafuku, H. et al. Clinical and ultrasound features associated with congenital cytomegalovirus infection as potential predictors for targeted newborn screening in high-risk pregnancies. Sci Rep. 10 (1), 2020, 19706.
4) Katow, S. Surveillance of congenital rubella syndrome in Japan,1978-2002 : effect of revision of the immunization law. Vaccine. 22 (29-30), 2004, 4084-91.
6) 先天性トキソプラズマ&サイトメガロウイルス感染症 患者会「トーチの会」. 感染経路等掲示用ポスター. https://toxocmv.org/pdf/poster1.pdf [2022. 6. 21]
7) 熱帯病治療薬研究班 オーファンドラッグ中央保管機関. 研究実施医療機関 (2021年10月現在). https://www.nettai.org/研究班と中央保管機関/ [2022.7.5]
8) Luck, SE. et al. Congenital Cytomegalovirus : A European expert consensus statement on diagnosis and management. Pediatr Infect Dis J. 36 (12), 2017, 1205-13.
P.283 掲載の参考文献
1) 全国視覚特別支援学校及び小・中学校弱視学級児童生徒の視覚障害原因等に関する調査研究 : 2015年度調査 : 報告書 http://www.human.tsukuba.ac.jp/~kakizawa/images/pdf/report.pdf [2022. 6. 7]
2) 平岡美依奈ほか. 超低出生体重児における未熟児網膜症 : 東京都多施設研究. 日本眼科学会雑誌. 108 (10), 2004, 600-5.
3) 太刀川貴子ほか. 超低出生体重児における未熟児網膜症 : 東京都多施設研究. 日本眼科学会雑誌. 122 (2), 2018, 103-13.
4) 周藤真ほか. スマートフォンによる前眼部および眼底撮影. 日本眼科学会雑誌. 118 (1). 2014, 7-14.
6) 清田眞理子ほか. 未熟児網膜症の初回検査時期の検討. 日本眼科学会雑誌. 114 (4), 2010, 356-61.
7) Early treatment for retinopathy of prematurity cooperative group. Revised indications for the treatment of retinopathy of prematurity : results of the early treatment for retinopathy of prematurity randomized trial. Arch Ophthalmol. 121 (12), 2003, 1684-94.
8) 寺崎浩子ほか. 未熟児網膜症に対する抗VEGF療法の手引き. 日本眼科学会雑誌. 124 (12), 2020,1013-9.
9) Tan, QQ. et al. Development of refractive error in children treated for retinopathy of prematurity with anti-vascular endothelial growth factor (anti-VEGF) agents : A meta-analysis and systematic review. PLoS One. 14 (12), 2019, e0225643.
10) Chiang, MF. et al. International classification of retinopathy of prematurity, third edition. Ophthalmology. 128 (10), 2021, e51-68.
P.288 掲載の参考文献
1) 奥山和男. 新生児の体温と発熱. 日本医師会雑誌. 89 (11), 1983, 1879-88.
2) 大木康史ほか. 新生児寒冷障害の3例 : 本邦報告例のまとめ. 小児科臨床. 46 (8), 1993, 1939-43.
3) 橋本武夫. 新生児疾患アトラス : 新生児寒冷障害. Neonatal Care. 19 (2), 2006, 106-7.
4) 仁志田博司. "体温調節と保温". 新生児学入門. 第5版. 東京, 医学書院, 2018, 123-31.
5) Klaus, MH. et al. "The physical enviroment". Care of the high-risk neonates. 5th ed. Philadelphia, W. B. Saunders, 2001, 130-46.
6) Tafari, N. et al. Aspects of rewarming newborn infants with severe accidental hypothermia. Acta Paediatr Scand. 63 (4), 1974, 595-600.
7) Racine, J. et al. Severe hypothermia in infants. Helv Paediatr Acta. 37 (4), 1982, 317-22.
8) Sofer, S. et al. Improved outcome of hypothermic infants. Pediatr Emerg Care. 2 (4), 1986, 211-4.
P.292 掲載の参考文献
1) 磯部健一ほか. 新生児離脱症候群の管理と薬物代謝 : 抗痙攣剤と向精神薬. 周産期学シンポジウム. 14, 1996, 65-75.
2) Finnegan, LP. et al. Neonatal abstinence syndrome : assessment and management. Addict Dis. 2 (1-2), 1975, 141-58.
3) Towers, CV. et al. Neonatal Head Circumference in Newborns With Neonatal Abstinence Syndrome. Pediatrics.143 (1), 2019, e20180541.
4) Morimoto, D. et al. Head circumference in infants with nonopiate-induced neonatal abstinence syndrome. CNS Spectr. 26 (5). 2021, 509-12.
P.298 掲載の参考文献
1) Saarinen, UM. et al. Developmental changes in red blood cell counts and indices of infants after exclusion of iron deficiency by laboratory criteria and continuous iron supplementation. J Pediatr. 92 (3), 1978, 412-6.
2) Timothy, MB. et al. "Developmental Erythropoiesis". Fetal and Neonatal Physiology. 6th ed. Polin, R. et al. ed. Amsterdam, Elsevier, 2021, 1104-24.
3) Gomella,TL. et al. "Polycythemia : On Call". Gomella's Neonatology : Management, Procedures, On-call Problems, Diseases, and Drugs, 8th ed. New York, McGraw-Hill, 2020, 686-93.
4) Jeffery, J. et al. Reference ranges for hematocrit and blood hemoglobin concentration during the neonatal period : data from a multihospital health care system. Pediatrics.123 (2), 2009, e333-7.
5) 高橋幸博. "血液系の基礎と臨床 : 多血症". 血液系の基礎と臨床. 新生児学入門. 第5版. 仁志田博司編. 東京, 医学書院, 2018, 309-11.
6) Alfirevic, A. et al. Isovolemic hemodilution in a patient with polycythemia vera undergoing deep hypothermic circulatory arrest. Can J Anaesth. 54 (5), 2007,402-3.
7) Dempsey, EM. et al. Short and long term outcomes following partial exchange transfusion in the polycythemic newborn : a systematic review. Arch Dis Child Fetal Neonatal Ed. 91 (1), 2005, F2-6.

第4章 母体疾患が胎児・新生児に与える影響

P.307 掲載の参考文献
1) 平松祐司ほか. 日本糖尿病・妊娠学会と日本糖尿病学会との合同委員会 妊娠中の糖代謝異常と診断基準の統一化について. 糖尿病. 58 (10), 2015, 801-3.
2) Ornoy, A. et al. Effect of maternal diabetes on the embryo, fetus, and children : congenital anomalies, genetic and epigenetic changes and developmental outcomes. Birth Defects Res C Embryo Today. 105 (1), 2015, 53-72.
3) 内山温. "内分泌疾患を有する母体が児に及ぼす影響". 新版 新生児内分泌ハンドブック. 新生児内分泌研究会 編著. 大阪, メディカ出版, 2020, 226-36.
5) Garg, M. et al. "Disorders of carbohydrate metabolism in the neonate". Fanaroff & Martin's Neonatal-perinatal medicine 11th ed. Philadelphia, Elsevier, 2020, 1584-610.
6) Xuan, DS. et al. Brain development in infants of mothers with gestational diabetes mellitus : a diffusion tensor imaging study. J Comput Assist Tomogr. 44 (6), 2020, 947-52.
7) Rizzo, TA. et al. Early malnutrition and child neurobehavioral development : insights from the study of children of diabetic mothers. Child Dev. 68 (1), 1997, 26-38.
8) Lowe, WL Jr. et al. Hyperglycemia and Adverse Pregnancy Outcome Follow-up Study (HAPO FUS) : Maternal gestational diabetes mellitus and childhood glucose metabolism. Diabetes Care. 42 (3), 2019, 372-80.
9) Bianco, ME. et al. Hyperglycemia during pregnancy and long-term offspring outcomes. Curr Diab Rep. 19 (12), 2019, 143.
10) Perak, AM. et al. Associations of maternal cardiovascular health in pregnancy with offspring cardiovascular health in early adolescence. JAMA. 325 (7), 2021, 658-68.
P.313 掲載の参考文献
1) 日本小児内分泌学会編. "新生児内分泌学". 小児内分泌学. 改訂第2版. 東京, 診断と治療社, 2016, 148-51.
2) Alexander, EK. et al. Timing and magnitude of increases in levothyroxine requirements during pregnancy in women with hypothyroidism. N Engl J med. 351 (3), 2004, 241-9.
3) Clementi, M. et al. Methimazole embryopathy : delineation of the phenotype. Am J Med Genet. 83 (1), 1999, 43-6.
4) 荒田尚子ほか. 妊娠初期に投与されたチアマゾール (MMI) の妊娠結果に与える影響に関する前向き研究 (Pregnancy Outcome of Exposure to Methimazole Study : POEM study) : 中間報告. https://www.pmda.go.jp/files/000145714.pdf [2022. 6. 25]
5) 日本甲状腺学会編. バセドウ病治療ガイドライン 2019. 東京, 南江堂, 2019, 204p.
6) Uehara, M. et al. Risk factors for neonatal thyroid dysfunction in pregnancies complicated by Graves' disease. Eur J Obstet Gynecol Reprod Biol. 177, 2014, 89-93.
7) 長谷川行洋. "甲状腺疾患先天性甲状腺疾患 : 一過性甲状腺機能低下症" たのしく学ぶ小児内分泌. 東京, 診断と治療社, 2015, 132.
8) Momotani, N. et al. Antithyroid drug therapy for Graves'disease during pregnancy. Optimal regimen for fetal thyroid status. N Engl J Med. 315 (1), l986, 24-8.
9) Leger, J. Management of fetal and neonatal Graves' disease. Horm Res Paediatr. 87 (1), 2017, 1-6.
10) Umemoto, M. et al. Propylthiouracil-induced hepatic failure with fetal outcome. Clin Pediatr Endocrinol. 6, 1997, 73-5.
P.320 掲載の参考文献
1) 厚生労働科学研究費補助金難治性疾患等政策研究事業 自己免疫疾患に関する調査研究 (自己免疫版) ほか編. 全身性エリテマトーデス診療ガイドライン 2019. 東京, 南山堂, 2019, 261p.
2) 長谷川稔. 自己抗体と皮膚病変からみていく膠原病診療. J Environ Dermatol Cutan Allergol. 8 (4), 2014, 231-8.
3) 平成27年度日本医療研究開発機構成育疾患克服等総合研究事業「抗リン脂質抗体症候群合併妊娠の治療及び予後に関する研究」研究班編. 抗リン脂質抗体症候群合併妊娠の診療ガイドライン. 東京, 南山堂, 2016, 76p.
4) 平成22年度~平成24年度 厚生労働科学研究費補助金 成育疾患克服等次世代育成基盤研究事業「自己抗体陽性女性の妊娠管理指針の作成及び 新生児ループスの発症リスクの軽減に関する研究」研究班編. 抗SS-A 抗体陽性女性の妊娠に関する診療の手引き. 2013. https://www.ncchd.go.jp/hospital/about/section/perinatal/bosei/699ba3ce063e73aa36e1461f8196a7bada02fca6.pdf [2022. 6. 19]
5) Lee, LA. et al. The demonstration of SS-A/Ro antigen in human fetal tissues and in neonatal and adult skin. J Invest Dermatol. 85 (2), 1985, 143-6.
6) 金子修也. "新生児ループス". 小児疾患診療のための病態生理 2. 改訂第6版. 小児内科 53巻増刊. 小児内科・小児外科編集委員会共編. 東京, 東京医学社, 2022, 960-4.
7) 横川直人ほか. 新生児ループス. 日本臨床免疫学会会誌. 40 (2), 2017, 124-30.
8) Gryka-Marton, M. et al. An overview of neonatal lupus with anti-ro characteristics. Int J Mol Sci. 22 (17), 2021, 9281.
9) Routsias, JG. et al. Sjogren's syndrome--study of autoantigens and autoantibodies. Clin Rev Allergy Immunol. 32 (3), 2007, 238-51.
10) 白石公. 母体由来の抗SSA抗SSB抗体による心筋細胞障害のメカニズムについて. 日本小児循環器学会雑誌. 24 (2), 2008, 124-8.
11) 阪本昌樹ほか. 新生児ループスによる急性肝不全の1例. 日本小児栄養消化器肝臓学会雑誌. 34 (1), 2020, 12-9.
12) 横川直人. ヒドロキシクロロキンによる抗SS-A抗体陽性女性の妊娠での先天性房室ブロックの再発抑制 : 医師主導臨床試験 (J-PATCH). https://jrct.niph.go.jp/latest-detail/jRCTs031180312 [2022. 6. 25]
13) 小児の臓器移植および免疫不全状態における予防接種ガイドライン作成委員会. 小児の臓器移植および免疫不全状態における予防接種ガイドライン (追補版) 2020. 2020. https://www.jspid.jp/wp-content/uploads/2021/10/zouki_tsuiho.pdf [2022. 6. 25]
P.326 掲載の参考文献
1) 宮川義隆ほか. 妊娠合併特発性血小板減少性紫斑病診療の参照ガイド. 臨床血液. 55 (8), 2014, 934-47.
2) Fujimura, K. et al. Nationwide study of idiopathic thrombocytopenic purpura in pregnant women and the clinical influence on neonates. Int J Hematol. 75 (4), 2002, 426-33.
3) Gill, KK. et al. Management of idiopathic thrombocytopenic purpura in pregnancy. Semin Hematol. 37 (3), 2000, 275-89.
4) Koyama, S. et al. Prenatal diagnosis of fatal intracranial hemorrhage in pregnancy complicated by idiopathic thrombocytopenic purpura. Prenat Diagn. 30 (5), 2010, 489-91.
5) Neunert, C. et al. The American society of Hematology 2011 evidence-based practice guideline for immune thrombocytopenia. Blood. 117 (16), 2011, 4190-207.
6) Provan, D. et al. Updated international consensus report on the investigation and management of primary immune thrombocytopenia. Blood Adv. 3 (22), 2019, 3780-817.
7) 西久保敏也. "新生児疾患 : 新生児血小板減少症". 小児科ケースカンファレンス. 小児科診療 80巻増刊. 東京, 診断と治療社, 2017, 176-9.
8) 笹原洋二. 先天性血小板減少症の診断と分子病態. 小児科. 55 (1), 2014, 105-14.
P.333 掲載の参考文献
1) 出口雅士ほか. 厚生労働科学特別研究事業. 新型コロナウイルス感染症流行下における, 妊婦に対する適切な支援供給体制構築のための研究. 日本におけるCOVID-19 妊婦の現状 : 妊婦レジストリの解析結果 (2022年1月31日迄の登録症例). https://www.jsog.or.jp/news/pdf/20220301_COVID19.pdf [2022. 6. 23]
2) 荒田尚子ほか. 妊娠を起点とした将来の女性および次世代の糖尿病発症予防のために. 糖尿病と妊娠. 15 (1), 2015, 56-64.
3) Obata, S. et al. Psychological stress among pregnant and puerperal women in Japan during the coronavirus disease 2019 pandemic. J Obstet. Gynaecol. Res. 47 (9), 2021, 2990-3000.
4) Allotey, J. et al. SARS-CoV-2 positivity in offspring and timing of mother-to-child transmission : living systematic review and meta-analysis. BMJ. 376, 2022, e067696.
5) 日本新生児成育医学会ほか. 新型コロナウイルス感染症に対する出生後早期の新生児への対応について. 第5版. https://jsnhd.or.jp/doctor/pdf/COVID19JSNHD20211208.pdf [2022. 6. 23]
6) WHO. Living guidance for clinical management of COVID-19. 2019. https://www.who.int/publications/i/item/WHO-2019-nCoV-clinical-2021-2 [2022. 6. 23]
7) Shah, PS. et al. Classification system and case definition for SARS-CoV-2 infection in pregnant women, fetuses, and neonates. Acta Obstet Gynecol Scand. 99 (5), 2020, 565-8.
8) Raschetti, R. et al. Synthesis and systematic review of reported neonatal SARS-CoV-2 infections. Nat Commun. 11 (1), 2020, 5164.
9) Hecht, JL. et al. SARS-CoV-2 can infect the placenta and is not associated with specific placental histopathology : a series of 19 placentas from COVID-19-positive mothers. Mod Pathol. 33 (11), 2020, 2092-103.
10) Akin, IM. et al. Epidemiologic and clinical characteristics of neonates with late-onset COVID19 : 1year data of Turkish Neonatal Society. Eur J Pediatr. 181 (5), 2022, 1933-42.
11) 国立感染症研究所ほか. 新型コロナウイルス感染症 (COVID-19) 病原体検査の指針. 第5.1版. https://www.mhlw.go.jp/content/000914399.pdf [2022. 6. 23]

最近チェックした商品履歴

Loading...